On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

Contact Us

In addition to assembling a diversified team with expertise in each area of branding, investor relations, public relations and social media, we have developed a network of brands and partners to best serve both public and private companies. By engaging any one of our services, you will benefit from decades of experience accumulated by helping more than 250 companies achieve greater success.

Contact Us

    Your Name *

    Your Email *

    Subject

    Message:

    Get Your Copy of The StocksToBuyNow Newsletter

    You’re just a click and email verification away from joining hundreds of other subscribers receiving weekly trading ideas!

    From Our Blog

    Annovis Bio Inc. (NYSE: ANVS) Announces New Executive Team Members

    July 23, 2024

    Annovis Bio (NYSE: ANVS), a pioneering late-stage clinical drug platform company focusing on transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (“AD”) and Parkinson’s Disease (“PD”), is thrilled to welcome four seasoned professionals to its executive team. Maria Maccecchini, Ph.D., Founder, President, and CEO of Annovis Bio, said the company was delighted to have […]

    Rotate your device 90° to view site.